Logo image of BACK

IMAC HOLDINGS INC (BACK) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BACK - US44967K3023 - Common Stock

0.2 USD
-0.22 (-52.65%)
Last: 3/25/2025, 8:00:01 PM
0.1269 USD
-0.07 (-36.55%)
After Hours: 3/25/2025, 8:00:01 PM
Fundamental Rating

0

BACK gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. BACK has a bad profitability rating. Also its financial health evaluation is rather negative. BACK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • BACK had negative earnings in the past year.
  • BACK had a negative operating cash flow in the past year.
  • BACK had negative earnings in each of the past 5 years.
  • BACK had a negative operating cash flow in each of the past 5 years.
BACK Yearly Net Income VS EBIT VS OCF VS FCFBACK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

  • BACK has a worse Return On Assets (-993.10%) than 97.27% of its industry peers.
Industry RankSector Rank
ROA -993.1%
ROE N/A
ROIC N/A
ROA(3y)-342.4%
ROA(5y)-217.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BACK Yearly ROA, ROE, ROICBACK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 1K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for BACK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BACK Yearly Profit, Operating, Gross MarginsBACK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

0

2. Health

2.1 Basic Checks

  • BACK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BACK has more shares outstanding
  • There is no outstanding debt for BACK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BACK Yearly Shares OutstandingBACK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K 1M
BACK Yearly Total Debt VS Total AssetsBACK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

  • BACK has an Altman-Z score of -76.94. This is a bad value and indicates that BACK is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of BACK (-76.94) is worse than 93.64% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -76.94
ROIC/WACCN/A
WACC8.12%
BACK Yearly LT Debt VS Equity VS FCFBACK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M 15M

2.3 Liquidity

  • BACK has a Current Ratio of 0.08. This is a bad value and indicates that BACK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BACK has a worse Current ratio (0.08) than 92.73% of its industry peers.
  • A Quick Ratio of 0.08 indicates that BACK may have some problems paying its short term obligations.
  • BACK has a worse Quick ratio (0.08) than 92.73% of its industry peers.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
BACK Yearly Current Assets VS Current LiabilitesBACK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

1

3. Growth

3.1 Past

  • BACK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.07%, which is quite impressive.
  • BACK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -99.15%.
EPS 1Y (TTM)66.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.53%
Revenue 1Y (TTM)-99.15%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-96.42%

3.2 Future

  • BACK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.68% yearly.
  • The Revenue is expected to decrease by -41.42% on average over the next years. This is quite bad
EPS Next Y69.42%
EPS Next 2Y25.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

BACK Yearly Revenue VS EstimatesBACK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
BACK Yearly EPS VS EstimatesBACK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15

1

4. Valuation

4.1 Price/Earnings Ratio

  • BACK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BACK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BACK Price Earnings VS Forward Price EarningsBACK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BACK Per share dataBACK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as BACK's earnings are expected to grow with 25.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.68%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • BACK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

IMAC HOLDINGS INC

NASDAQ:BACK (3/25/2025, 8:00:01 PM)

After market: 0.1269 -0.07 (-36.55%)

0.2

-0.22 (-52.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)01-17
Earnings (Next)04-14
Inst Owners1.61%
Inst Owner Change0%
Ins Owners3.33%
Ins Owner Change0%
Market Cap674.00K
Revenue(TTM)72.10K
Net Income(TTM)-14.57M
Analysts82.86
Price Target8.41 (4105%)
Short Float %0.82%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-169.38%
Min EPS beat(2)-283.24%
Max EPS beat(2)-55.51%
EPS beat(4)1
Avg EPS beat(4)-88.1%
Min EPS beat(4)-283.24%
Max EPS beat(4)62.29%
EPS beat(8)1
Avg EPS beat(8)-131.33%
EPS beat(12)2
Avg EPS beat(12)-105.9%
EPS beat(16)5
Avg EPS beat(16)-68.76%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.35
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.76
EYN/A
EPS(NY)-3.55
Fwd EYN/A
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS0.02
BVpS-1.42
TBVpS-1.42
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -993.1%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-342.4%
ROA(5y)-217.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -76.94
F-Score2
WACC8.12%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.53%
EPS Next Y69.42%
EPS Next 2Y25.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-99.15%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-96.42%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y82.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.55%
OCF growth 3YN/A
OCF growth 5YN/A

IMAC HOLDINGS INC / BACK FAQ

Can you provide the ChartMill fundamental rating for IMAC HOLDINGS INC?

ChartMill assigns a fundamental rating of 0 / 10 to BACK.


What is the valuation status for BACK stock?

ChartMill assigns a valuation rating of 1 / 10 to IMAC HOLDINGS INC (BACK). This can be considered as Overvalued.


What is the profitability of BACK stock?

IMAC HOLDINGS INC (BACK) has a profitability rating of 0 / 10.


Can you provide the financial health for BACK stock?

The financial health rating of IMAC HOLDINGS INC (BACK) is 0 / 10.